Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality

Circulation

Volumn 96, Issue 10, 1997, Pages 3338-3345

  Berton, Giuseppe ^b   Citro, Tiziana ^b   Palmieri, Rosa ^b   Petucco, Stefania ^b   De Toni, Renzo ^b   Palatini, Paolo ^a  

^a Clinica Medica 1a   (Italy)

^b NONE

Author keywords

Heart failure; Microalbuminuria; Mortality; Myocardial infarction

Indexed keywords

ALBUMIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN TRANSPORT; PROTEINURIA; RADIOIMMUNOASSAY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030780566     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3338     Document Type: Article

References (34)

1. Viberti GC, Hill RD, Jarret RJ, Mahmud U, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430-1432.
2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310: 356-360.
3. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736-741.
4. Gerber LM, Shmukler C, Alderman MH. Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects. Arch Intern Med. 1992;152:373-377.
5. Kuusisto J, Mykkänen L, Pyörälä, Markku L. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:831-837.
6. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
7. Gosling P, Shearman CP. Increased levels of urinary proteins: markers of vascular permeability? Ann Clin Biochem. 1988;25: 150s-151s.
8. UK Prospective Diabetes Study Group. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglicaemia and hypertriglyceridaemia. Diabetologia. 1993;36:1021-1029.
9. Schnack C, Pietschmann P, Knobl P, Schuller E, Prager R. Apolipoprotein levels and atherogenic lipid fractions in relation to the degree of urinary albumin excretion in type 2 diabetes mellitus. Nephron. 1994;66:272-277.
10. Gosling P, Hughes EA, Reynolds JP, Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J. 1991;12:508-513.
11. Pasternak RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Braunwald E, ed. Heart Disease, 4th ed. Philadelphia, Pa: WB Saunders; 1992:1200-1223.
12. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
13. Erbel R. Comparison of single-plane and biplane volume determination by two-dimensional echocardiography, 1: asymmetric model hearts. Eur Heart J. 1982;3:469-474.
14. Bradows RG, Nichols D, Shaker G, Kubasik NP. Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care. 1986;9: 189-193.
15. Altman DG. Modelling survival, the Cox regression model. In: Practical Statistics for Medical Research. Chapman & Hall 1992: 387-394.
16. Eiskjaer H, Bagger JP, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition. Scand J Lab Invest. 1992;52:193-199.
17. Ellekilde G, von Eyben FE, Holm J, Hemmingsen L. Above-normal urinary excretion of albumin and retinol-binding protein in patients with acute myocardial infarction. Clin Chem. 1993;39:2350-2351.
18. Eiskjaer H, Mogensen CE, Schmitz A, Pedersen EB. Enhanced urinary excretion of albumin and α2-microglobulin in essential hypertension induced by atrial natriuretic peptide. Scand J Lab Invest. 1991;51:359-366.
19. Zimmerman RS, Trippodo NC, MacPhee AA, Martinez AJ, Barbee RW. High-dose atrial natriuretic peptide enhance albumin escape from the systemic but not the pulmonary circulation. Circ Res. 1990;67:461-468.
20. von Eyben FE, Holm J, Hemmingsen L, Ellekilde G. Albuminuria with or without streptokinase. Lancet. 1993;342:365-366.
21. Rouleau JL, Packer M, Moyè L, de Champlain J, Bichet D, Klein M, Rouleau JR, Sussex B, Arnold JM, Sestier F, Parker JO, McEwan P, Bernstein V, Cuddy TE, Lamas G, Gottlieb S, McCans J, Nadeau C, Delage F, Wun CC, Pfeffer MA. Prognostic significance of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24: 583-591.
22. Omland T, Bonarjee VVS, Lie RT, Caidahl K. Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. Am J Cardiol. 1995;76:230-235.
23. Foy SG, Crozier IG, Richards AM, Nicholls MG, Turner JG, Frampton CM, Ikram H. Neurohumoral changes after acute myocardial infarction: relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J. 1995;16:770-778.
24. Nash GB, Thomas PRS, Dormandy JA. Abnormal flow properties of a white blood cells in patients with severe ischaemia of the leg. BMJ. 1988;296:1699-1701.
25. Lucchesi Br, Mullane KM. Leukocytes and ischaemia-induced myocardial injury. Annu Rev Pharmacol Toxicol. 1986;26:201-224.
26. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994; 331:417-424.
27. Madsen EB, Gilpin E, Henning H. Evaluation of prognosis one year after myocardial infarction. J Am Coll Cardiol. 1983;1:985-993.
28. Gottlieb S, Moss AJ, McDermott M, Eberly S. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction. Am J Cardiol. 1992;69:977-984.
29. Omland T, Bonarjee VS, Nilsen DWT, Sundsfjord JA, Lie RL, Thibault G, Dickstein K. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J. 1993;70:409-414.
30. Herlitz J, Karlson BW, Richter A, Wiklund O, Jablonskiene D, Hjalmarson A. Prognosis in hypertensives with acute myocardial infarction. J Hypertens. 1992;10:1265-1271.
31. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22:1788-1794.
32. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agent. J Am Coll Cardiol. 1993;21:920-925.
33. Willerson JT, Cohn JN. Cardiovascular Medicine. New York, NY: Churchill Livingstone; 1995.
34. Launbjerg J, Berning J, Fruengaard P, Eliasen P, Bork-Johnsen K, Eiken P, Appleyard M. Risk stratification after acute myocardial infarction by means of echocardiographic wall motion scoring and Killip classification. Cardiology. 1992;80:375-381.